Overview
2023 saw the long-awaited adoption of the new general USP chapters <665> and <1665> to address the risk of extractables and leachables (E&L) in plastic components and systems used in the manufacture of pharmaceutical products.
USP <665> is mandatory and comes into full effect on May 1, 2026. Although the time left is short, there is still enough time to implement the USP’s regulatory measures.
Objective
This webinar is aimed at all those who aren’t yet familiar with USPs <1665> and <665> and would like an introduction. The use of USPs <1665> and <665> is expertly explained using a case application example, so a real-life scenario is presented. You will also have the opportunity to network with SGS experts to answer your questions on the topic.
Agenda
Target Audience: The webinar is aimed at anyone who needs to qualify processes in the area of pharmaceutical production, single-use or material suppliers, buyers of SUS and managers in QA as well as regulatory affairs.
Language: English
Can't make a live session? Register now and receive a complimentary recording after the live event. For further information, please contact: healthscience@sgs.com
_1733753892524